HomeIMR • FRA
Follow
AC Immune SA
Previous close
€2.76
Day range
€2.71 - €2.76
Year range
€1.60 - €4.65
Market cap
293.63M USD
Avg Volume
2.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 14.80M | 1,480,000.00% |
Operating expense | 3.70M | 3.82% |
Net income | -4.74M | 74.70% |
Net profit margin | -32.05 | 100.00% |
Earnings per share | -0.05 | 75.00% |
EBITDA | -3.12M | 82.87% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 103.05M | -15.94% |
Total assets | 182.81M | -1.68% |
Total liabilities | 22.17M | 30.83% |
Total equity | 160.64M | — |
Shares outstanding | 93.95M | — |
Price to book | 1.61 | — |
Return on assets | -5.43% | — |
Return on capital | -6.06% | — |
Cash Flow
Net change in cash
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.74M | 74.70% |
Cash from operations | -16.19M | 6.99% |
Cash from investing | 23.28M | 369.45% |
Cash from financing | 41.03M | 27,270.86% |
Net change in cash | 46.57M | 460.51% |
Free cash flow | -14.78M | -37.80% |
About
Founded
2003
Website
Employees
147